Loading...
Docoh

Repligen (RGEN)

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Company profile

Ticker
RGEN
Exchange
CEO
Anthony Hunt
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Repligen Sweden AB • Repligen GmbH • Repligen Singapore Pte. Ltd. • Repligen Europe B.V. • Repligen (Shanghai) Biotechnology Co. Ltd. • Repligen Japan LLC • Repligen India Private Limited • Repligen Korea Co., Ltd. • ARTeSYN Biosolutions Holdings Ireland Limited • ARTeSYN Biosolutions Ireland Limited ...
IRS number
42729386

RGEN stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$232.50
Low target
$220.00
High target
$245.00
Keybanc
Maintains
Overweight
$245.00
28 Apr 22
SVB Leerink
Maintains
Outperform
$220.00
28 Apr 22

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

27 Apr 22
26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 584.64M 584.64M 584.64M 584.64M 584.64M 584.64M
Cash burn (monthly) 6.39M 10.56M (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 18.37M 30.35M n/a n/a n/a n/a
Cash remaining 566.27M 554.29M n/a n/a n/a n/a
Runway (months of cash) 88.6 52.5 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
26 May 22 Eglinton Manner Carrie Common Stock Grant Acquire A No No 0 1,024 0 1,481
26 May 22 Eglinton Manner Carrie Stock Option Common Stock Grant Acquire A No No 159.17 2,488 396.01K 2,488
26 May 22 Muir Glenn P Common Stock Grant Acquire A No No 0 534 0 6,896
26 May 22 Muir Glenn P Stock Option Common Stock Grant Acquire A No No 159.17 1,298 206.6K 1,298
26 May 22 Dawes Karen A Common Stock Grant Acquire A No No 0 644 0 77,176
26 May 22 Dawes Karen A Stock Option Common Stock Grant Acquire A No No 159.17 1,565 249.1K 1,565
26 May 22 Barthelemy Nicolas Common Stock Grant Acquire A No No 0 534 0 2,081
26 May 22 Barthelemy Nicolas Stock Option Common Stock Grant Acquire A No No 159.17 1,298 206.6K 1,298
88.5% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 437 497 -12.1%
Opened positions 42 83 -49.4%
Closed positions 102 59 +72.9%
Increased positions 176 149 +18.1%
Reduced positions 138 178 -22.5%
13F shares Current Prev Q Change
Total value 9.04B 13.45B -32.8%
Total shares 48.16M 47.24M +1.9%
Total puts 315.7K 241.2K +30.9%
Total calls 245.9K 203.3K +21.0%
Total put/call ratio 1.3 1.2 +8.2%
Largest owners Shares Value Change
BLK Blackrock 5.37M $1.01B +3.4%
Vanguard 4.89M $920.06M -0.4%
TROW T. Rowe Price 3.78M $710.25M +24.1%
IVZ Invesco 1.76M $330.32M +3.9%
Brown Capital Management 1.45M $273.63M +44.0%
WCM Investment Management 1.39M $261.94M +2.3%
STT State Street 1.38M $259.76M +2.5%
AMP Ameriprise Financial 1.35M $254.82M +13.0%
Alliancebernstein 1.28M $241.43M +23.2%
MCQEF Macquarie 1.16M $217.42M +18.5%
Largest transactions Shares Bought/sold Change
TROW T. Rowe Price 3.78M +733.45K +24.1%
Norges Bank 0 -524.39K EXIT
Brown Capital Management 1.45M +444.65K +44.0%
Millennium Management 4.64K -304.84K -98.5%
Ardevora Asset Management 0 -247.68K EXIT
Alliancebernstein 1.28M +241.39K +23.2%
1832 Asset Management 442.5K -228.7K -34.1%
Gilder Gagnon Howe & Co 222.85K -217.72K -49.4%
Allspring Global Investments 609.8K -215.77K -26.1%
Fred Alger Management 1.03M -192.78K -15.8%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: applied, applying, Aquisition, bifurcation, BioFlex, biotech, branded, carryforward, classification, closer, Ecolab, EPS, feature, fluid, focused, forward, hose, increasingly, irrevocably, Jason, Jersey, LeaseQuery, long, longer, Meola, milestone, month, newly, Newton, Nisler, NTM, numerator, occupancy, opening, parent, payout, pharmaceutical, Ralph, rapid, removing, reversed, single, split, stable, Topic, trademark, tradename, typically, unlimited
Removed: abundance, accretion, ahead, Alphinity, Amendment, April, assumption, Auburn, August, automated, beneficial, Board, combining, commencement, Creek, custom, deliver, Derek, differentiated, downturn, efficiency, EMT, enabling, established, Estonia, evaluating, executed, expanding, extension, extrusion, fabricated, FASB, feet, finalization, Gagne, holder, integrated, intent, leadership, licensing, Mallone, Marlborough, Masser, medicine, Michael, minimize, Nevada, NMS, October, outbreak, path, pay, permitted, preexisting, prep, presence, processing, quickly, ramp, range, recognizing, relating, scale, settlement, silicone, slowdown, space, square, stay, streamline, SU, tangible, team, traditional, transition, transparency, ultimate, utilizing, Waterford, William